<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Obstetric complications are the hallmark of <z:e sem="disease" ids="C0085278" disease_type="Disease or Syndrome" abbrv="">antiphospholipid syndrome</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain><z:e sem="disease" ids="C0000809" disease_type="Disease or Syndrome" abbrv="">Recurrent miscarriage</z:e>, early delivery, <z:hpo ids='HP_0001562'>oligohydramnios</z:hpo>, <z:e sem="disease" ids="C0728731" disease_type="Disease or Syndrome" abbrv="">prematurity</z:e>, <z:hpo ids='HP_0001511'>intrauterine growth restriction</z:hpo>, <z:e sem="disease" ids="C0015930" disease_type="Disease or Syndrome" abbrv="">fetal distress</z:e>, fetal or neonatal <z:mp ids='MP_0005048'>thrombosis</z:mp>, pre-<z:hpo ids='HP_0100601'>eclampsia</z:hpo>/<z:hpo ids='HP_0100601'>eclampsia</z:hpo>, <z:e sem="disease" ids="C0162739" disease_type="Disease or Syndrome" abbrv="HELLP">HELLP syndrome</z:e>, arterial or <z:hpo ids='HP_0004936'>venous thrombosis</z:hpo> and <z:mp ids='MP_0006372'>placental insufficiency</z:mp> are the most severe APS-related complication for pregnant women </plain></SENT>
<SENT sid="2" pm="."><plain><z:hpo ids='HP_0003613'>Antiphospholipid antibodies</z:hpo> promote activation of endothelial cells, monocytes and platelets, causing an overproduction of tissue factor and <z:chebi fb="0" ids="15627">thromboxane A2</z:chebi> </plain></SENT>
<SENT sid="3" pm="."><plain>Complement activation might have a central pathogenetic role </plain></SENT>
<SENT sid="4" pm="."><plain>These factors, associated with the typical changes in the hemostatic system during <z:mpath ids='MPATH_458'>normal</z:mpath> pregnancy, result in a <z:e sem="disease" ids="C0398623" disease_type="Disease or Syndrome" abbrv="">hypercoagulable state</z:e> </plain></SENT>
<SENT sid="5" pm="."><plain>This is responsible of <z:mp ids='MP_0005048'>thrombosis</z:mp> that is presumed to provoke many of the <z:e sem="disease" ids="C0032962" disease_type="Disease or Syndrome" abbrv="">pregnancy complications</z:e> associated with APS </plain></SENT>
<SENT sid="6" pm="."><plain>Obstetric care is based on combined medical-obstetric high-risk management and treatment with the association between aspirin and <z:chebi fb="5" ids="28304">heparin</z:chebi> </plain></SENT>
<SENT sid="7" pm="."><plain>This review aims to deter- mine the current state of the art of APS by investigating the knowledge achievements of recent years, to provide the most appropriate diagnostic and therapeutic management for pregnant women suffering from this syndrome </plain></SENT>
</text></document>